---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-168285"
form_type: "8-K"
ticker: "PMVP"
cik: "0001699382"
company_name: "PMV Pharmaceuticals, Inc."
filed_at: "2022-06-06T23:59:59+00:00"
generated_at: "2026-06-25T04:24:13.272167+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# PMV Pharma stockholders re-elect Levine and Baum, approve say-on-pay and one-year frequency, ratify EY

## Summary
- Arnold Levine elected as Class II director with 29,469,991 FOR votes; Charles Baum with 29,134,747 FOR.
- Non-binding say-on-pay approved: 32,962,908 FOR, 872,088 AGAINST.
- Stockholders favored one-year frequency for future advisory votes on executive compensation (33,827,318 FOR one year).
- Ernst & Young ratified as independent auditor for FY2022: 35,746,657 FOR, 4,223 AGAINST, 451 abstain.

## SEC filing metadata
- accession: 0001193125-22-168285
- form_type: 8-K
- ticker: PMVP
- cik: 0001699382
- company_name: PMV Pharmaceuticals, Inc.
- filed_at: 2022-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/0001193125-22-168285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/d274679d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-168285
- JSON: https://secwatch.observer/filing/0001193125-22-168285.json
- Plain text: https://secwatch.observer/filing/0001193125-22-168285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.